Preclinical Results from Osteoarthritis Gene Therapy Studies Published by GeneQuine and Collaborators in Leading Arthritis Journal [ 14 Sep 2018 ]

A scientific paper reporting preclinical small and large animal data of the gene therapy approach for osteoarthritis developed by GeneQuine and Baylor College of Medicine was published in “Arthritis & Rheumatology”, a leading peer-reviewed journal in the field. The data suggest symptomatic and disease-modifying efficacy in osteoarthritis treatment.

More


Positive Data on Osteoarthritis Gene Therapy Generated by GeneQuine and Collaborators Presented at OARSI World Congress (26 – 29 April 2018, Liverpool) [ 20 Apr 2018 ]

The osteoarthritis gene therapy approach developed by Baylor College of Medicine and GeneQuine demonstrated symptomatic and disease-modifying efficacy in small and large osteoarthritis animal models.

More


GeneQuine to attend Biopartnering and Investment Conference BioTrinity in London April 23 – 25, 2018 [ 12 Apr 2018 ]

Meet GeneQuine’s CEO Kilian Guse at BioTrinity to discuss partnering and investment options.

More


GeneQuine Featured on Leading Animal Health News Platform Animal Pharm [ 22 Mar 2018 ]

GeneQuine's CEO was interviewed by Animal Pharm regarding the company's partnering strategy for osteoarthritis product candidates for horses and dogs.

More